Patient Choice in HIV PrEP
Empowering Patients to Choose the Right HIV PrEP for Them

Released: April 25, 2023

Jona Tanguay
Jona Tanguay, MMSc, PA-C, AAHIVS

Activity

Progress
1
Course Completed

In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:

  • Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF
  • Differences in adverse effect profiles between 4 PrEP options
  • Potential for HIV resistance
  • Requirements for compliance and monitoring
  • Evidence in populations with various acquisition behaviors
  • Drug interaction implications